IMMUNIC, INC.

Nasdaq:IMUX

Pharmaceutical Preparations·NEW YORK, X1

CEO

Vitt Daniel

CFO

Whaley Glenn

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/26/26	→
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
2/26/26	Q1 FY2026	→
11/13/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
11/7/24	Q4 FY2024	→
8/8/24	Q3 FY2024	→
5/8/24	Q2 FY2024	→
↓

News (8-K)

60 shown

Filed	Type	Description
2/13/26	Exec Change	Entry into a Material Definitive Agreement	→
1/6/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
1/5/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/25/25	Other	Other Events	→
7/11/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/27/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
8/27/25	S-8	S-8	→
5/30/25	424B5	424B5	→
5/28/25	424B5	424B5	→
4/9/25	424B5	424B5	→
7/2/24	S-8	S-8	→
6/10/24	424B5	424B5	→
↓

Filing History(766 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G

Mar 4, 2026

0001172661-26-001332

—

13.9 KB

Mar 4, 2026

0001193805-26-000217

—

28.0 KB

DEF 14A

Mar 2, 2026

0001193805-26-000201

Apr 14, 2026

227.7 KB

Feb 27, 2026

0000921895-26-000568OWNERSHIP DOCUMENT

Feb 17, 2026

40.0 KB

Feb 27, 2026

0000921895-26-000567OWNERSHIP DOCUMENT

Feb 17, 2026

3.0 KB

10-K

Feb 26, 2026

0001280776-26-00000510-K

Dec 31, 2025

24.3 MB

8-K

Feb 26, 2026

0001193805-26-000181

Feb 26, 2026

257.3 KB

SCHEDULE 13G

Feb 24, 2026

0001831942-26-000012

—

15.5 KB

SCHEDULE 13G

Feb 24, 2026

0001493152-26-007882

—

23.9 KB

SCHEDULE 13D

Feb 20, 2026

0000921895-26-000531

—

63.8 KB

PRE 14A

Feb 20, 2026

0001193805-26-000167

Apr 14, 2026

221.9 KB

SCHEDULE 13G

Feb 20, 2026

0001213900-26-018848

—

22.2 KB

SCHEDULE 13G

Feb 19, 2026

0001213900-26-018443

—

46.2 KB

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001176

—

10.6 KB

SCHEDULE 13G/A

Feb 17, 2026

0000921895-26-000467

—

10.5 KB

SCHEDULE 13G/A

Feb 13, 2026

0001104659-26-015336

—

10.8 KB

8-K

Feb 13, 2026

0001193805-26-000129

Feb 12, 2026

1.3 MB

SCHEDULE 13G/A

Feb 2, 2026

0001716774-26-000009

—

8.7 KB

8-K

Jan 6, 2026

0001193805-26-000011

Jan 5, 2026

184.1 KB

8-K

Jan 5, 2026

0001193805-26-000007

Dec 29, 2025

415.3 KB

SCHEDULE 13G

Dec 8, 2025

0001274173-25-000336

—

9.8 KB

SCHEDULE 13G/A

Nov 14, 2025

0001172661-25-005186

—

10.6 KB

SCHEDULE 13G/A

Nov 14, 2025

0000919574-25-006917

—

23.5 KB

8-K

Nov 13, 2025

0001193805-25-001570

Nov 13, 2025

273.6 KB

10-Q

Nov 13, 2025

0001280776-25-00001710-Q

Sep 30, 2025

12.6 MB

25 filings shown

IMMUNIC, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(766 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/2/26	DEF 14A	DEF 14A	→
2/20/26	PRE 14A	PRE 14A	→
4/22/25	DEFA14A	DEFA14A	→
4/22/25	DEF 14A	DEF 14A	→
4/23/24	DEF 14A	DEF 14A	→
2/5/24	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
2/27/26	3	OWNERSHIP DOCUMENT	→
2/27/26	3	OWNERSHIP DOCUMENT	→
7/18/25	4	4	→
7/18/25	4	4	→
7/18/25	4	4	→
7/18/25	4	4	→
↓

Filed	Form	Description
3/4/26	SCHEDULE 13G	SCHEDULE 13G	→
3/4/26	D	D	→
2/24/26	SCHEDULE 13G	SCHEDULE 13G	→
2/24/26	SCHEDULE 13G	SCHEDULE 13G	→
2/20/26	SCHEDULE 13D	SCHEDULE 13D	→
2/20/26	SCHEDULE 13G	SCHEDULE 13G	→
↓